Your browser doesn't support javascript.
loading
Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.
van der Kouwe, E; Heller, G; Czibere, A; Pulikkan, J A; Agreiter, C; Castilla, L H; Delwel, R; Di Ruscio, A; Ebralidze, A K; Forte, M; Grebien, F; Heyes, E; Kazianka, L; Klinger, J; Kornauth, C; Le, T; Lind, K; Barbosa, I A M; Pemovska, T; Pichler, A; Schmolke, A-S; Schweicker, C M; Sill, H; Sperr, W R; Spittler, A; Surapally, S; Trinh, B Q; Valent, P; Vanura, K; Welner, R S; Zuber, J; Tenen, D G; Staber, P B.
Affiliation
  • van der Kouwe E; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Heller G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Czibere A; Pfizer Inc., Cambridge, MA.
  • Pulikkan JA; Versiti Blood Research Institute, Milwaukee, WI.
  • Agreiter C; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Castilla LH; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA.
  • Delwel R; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Di Ruscio A; Oncode Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Ebralidze AK; Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA.
  • Forte M; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Grebien F; Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Heyes E; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA.
  • Kazianka L; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Klinger J; Institute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Kornauth C; Institute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Le T; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Lind K; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Barbosa IAM; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Pemovska T; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Pichler A; Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
  • Schmolke AS; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Schweicker CM; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Sill H; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Sperr WR; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Spittler A; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Surapally S; Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
  • Trinh BQ; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Valent P; Core Facility Flow Cytometry and Surgical Research Laboratories, and.
  • Vanura K; Versiti Blood Research Institute, Milwaukee, WI.
  • Welner RS; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA.
  • Zuber J; Department of Medicine I, Division of Hematology and Hemostaseology, and.
  • Tenen DG; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Staber PB; Department of Medicine I, Division of Hematology and Hemostaseology, and.
Blood ; 138(15): 1345-1358, 2021 10 14.
Article de En | MEDLINE | ID: mdl-34010414
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Régulation de l'expression des gènes dans la leucémie / Transactivateurs / Protéines proto-oncogènes / Sous-unité alpha 2 du facteur CBF / Sous-unités bêta du facteur CBF Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Blood Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Régulation de l'expression des gènes dans la leucémie / Transactivateurs / Protéines proto-oncogènes / Sous-unité alpha 2 du facteur CBF / Sous-unités bêta du facteur CBF Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Blood Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique